Quiet Periods Surrounding Offerings
Quick Answer
FINRA's research-analyst conflicts rule prohibits a member firm that underwrote or dealt in an IPO from publishing or distributing research on the subject company (and prohibits the analyst from making public appearances) for 10 calendar days after the offering date. For a secondary offering where the firm acted as manager or co-manager, the quiet period is 3 calendar days. Emerging Growth Companies (EGCs) are exempt from both quiet periods under the JOBS Act. The prior 15-day quiet periods around lock-up expirations were eliminated. Significant news or significant events about the subject company can be published or appeared on during a quiet period if legal/compliance authorizes the disclosure, documented in the supervisory file.
The quiet periods exist to prevent firms from using research to support deals they just underwrote. A "buy" report from the lead manager on the day after pricing is structurally indistinguishable from deal-promotion, so the rule shuts research down for a defined window after the offering. The principal supervising research has to know the windows by heart and document any reliance on the significant-news carve-out.
Post-Offering Quiet Periods: The Time Frames
| Offering Type | Member Firm's Role | Quiet Period |
|---|---|---|
| Initial Public Offering (IPO) | Underwriter or dealer in the deal | 10 calendar days after the offering date |
| Secondary offering | Manager or co-manager | 3 calendar days after the offering date |
During the quiet period:
- The member firm may NOT publish or distribute research reports on the subject company
- The research analyst may NOT make public appearances about the subject company
The 10-day and 3-day windows replaced the prior 40-day / 25-day periods that existed under the former NASD research-analyst rule. The shorter windows reflect a regulatory judgment that the original blackouts were too long given how rapidly information now flows.
The reach of the quiet period is asymmetric on offering type:
- IPO: anyone who underwrote OR dealt in the deal is in the quiet period; the rule reaches the entire syndicate plus dealers in the selling group
- Secondary: only managers or co-managers are in the quiet period; non-managing syndicate members and dealers are not blackout-restricted
The principal supervising research has to know the firm's role on each deal and apply the correct window. A firm that was a co-manager on Issuer X's IPO and a non-managing syndicate member on Issuer Y's secondary has a 10-day quiet period on X and no quiet period on Y.
Exam Tip: Gotchas
- The IPO quiet period is 10 CALENDAR days, not 10 business days. A Friday-pricing IPO ends its quiet period the second Monday after pricing, not 10 trading days later. The exam will give a date and ask when research can resume.
- The secondary quiet period is 3 CALENDAR days, also calendar. Three trading days is wrong; three calendar days is right.
- The IPO quiet period covers underwriters AND dealers; the secondary quiet period covers managers and co-managers only. The reach is wider for IPOs because the conflict is most severe for the firms that brought a brand-new issuer to market.
- The 40-day / 25-day periods are HISTORICAL. The current research-analyst conflicts rule replaced them with 10 / 3. An exam answer citing 40 or 25 is a wrong-answer trap.
Quiet Period Carve-Outs
Emerging Growth Companies (EGCs) Are Exempt
Under the JOBS Act of 2012, the post-IPO and post-secondary quiet periods do NOT apply to Emerging Growth Companies. An EGC is an issuer with less than approximately $1.235 billion (originally $1 billion, indexed) in annual gross revenues that has not yet reached the post-IPO timing thresholds.
The EGC carve-out reflects a legislative judgment that smaller, recently public issuers benefit from continuous research coverage and that the conflict-of-interest concern is outweighed by the information-flow concern. For Series 24 purposes, the principal has to know that EGCs are exempt: the rule is "no quiet period for EGC research."
Lock-Up Expiration Quiet Periods Have Been Eliminated
Under former NASD research-analyst rules, there were 15-day quiet periods around the expiration, waiver, or termination of a lock-up agreement. The current research-analyst conflicts rule eliminated those quiet periods. There is no longer a quiet period tied to lock-up expirations under the modern rule.
This is a high-frequency exam trap because the eliminated 15-day rule was on prior versions of the exam and may still appear in older study materials. The current rule has no lock-up quiet period.
Significant News and Significant Events
If the subject company has significant news or significant events during the quiet period, legal or compliance personnel may authorize publication of a research report or a public appearance during the window. The firm must document the authorization in the supervisory file.
What counts as "significant"? A material earnings announcement, a major M&A development, a regulatory event affecting the issuer's core business, or a market-moving disclosure that the firm's clients need updated research on. The carve-out is narrow and intentionally requires legal/compliance authorization rather than letting research and the analyst self-determine.
The supervisory file should contain:
- The specific event that triggered the request
- The legal/compliance authorization with date and signatory
- The substance of the published report or appearance
A regulator examining the firm's quiet-period compliance will ask for the file. The principal's job is to make sure it exists with all three elements.
Exam Tip: Gotchas
- EGCs are exempt from the quiet periods. This is the JOBS Act carve-out. The exam fact pattern with an EGC issuer should not produce a quiet-period violation.
- Lock-up expiration quiet periods are HISTORICAL and have been eliminated. The 15-day rule no longer exists. An exam answer citing 15 days for lock-up is wrong.
- The significant-news carve-out requires LEGAL/COMPLIANCE authorization. Research and the analyst cannot self-authorize; the documentation requirement is mandatory and is the principal's audit trail.
Booster Shot / Initiation of Coverage During a Quiet Period
The "booster shot" is industry slang for the first research report a manager / co-manager publishes after an offering: typically a buy or hold rating that signals continued support for the issuer. The research-analyst conflicts rule requires the booster shot to wait for the end of the quiet period:
- For an IPO, the booster shot must wait at least 10 calendar days after the offering date
- For a secondary offering, the booster shot must wait at least 3 calendar days after the offering date
A booster shot published inside the window without the significant-news carve-out is:
- A quiet-period breach under the research-analyst conflicts rule, AND
- Likely a Securities Act violation under the participating-broker research safe harbors, because a brand-new initiation of coverage timed to a deal cannot meet the regular-course requirement of those safe harbors
The double exposure (FINRA + SEC) is what makes the booster-shot trap so consequential. The firm is not just risking a FINRA fine; it is risking a federal securities-law violation for an illegal prospectus.
Exam Tip: Gotchas
- The booster shot must clear the quiet period. A 10-day IPO booster shot published on day 7 is a research-analyst-conflicts violation, even if the substance of the report is unobjectionable.
- A booster shot that fails the quiet period typically also fails the participating-broker research safe harbors. A first-ever note on the issuer the firm just took public cannot meet the regular-course requirement, so the safe harbor is lost too. Two violations from one report.
- The exam loves the timing trap. A Friday-priced IPO that "ended" 10 days later on the second Monday, and a research report published the prior Friday because the analyst counted business days. The clock is calendar, not business.